Invivyd @Invivyd
CDC now estimates COVID infections are rising in 34 U.S. states - and declining in zero.
Invivyd's latest data: pemivibart as well as next-gen mAb VYD2311 show continued in-vitro neutralizing activity against XFG, the currently dominant SARS-CoV-2 variant. Read more:
Invivyd's latest data: pemivibart as well as next-gen mAb VYD2311 show continued in-vitro neutralizing activity against XFG, the currently dominant SARS-CoV-2 variant. Read more: